Functional Brands Urges Vote on Reverse Split, Details Highly Dilutive $142.9M Blockchain Acquisition
MEHA is trading near its 52-week low of $0.057 (15% above the low) on elevated volume (3.4× avg).
Summary
Functional Brands Inc. is urging shareholders to vote on a reverse stock split to avoid delisting and provided further details on its previously announced, highly dilutive $142.9 million all-stock acquisition of BullionFX | Alchemy assets.
Key Events · Corporate Governance and Compliance · MEHA
-
Urgent Shareholder Vote Reminder
The company is urging shareholders to vote by May 27, 2026, on critical proposals including a reverse stock split to avoid Nasdaq delisting and approval of a new 2026 Equity Incentive Plan.
-
Elaboration on BullionFX Acquisition
Management provided a detailed strategic rationale for the previously announced $142.9 million all-stock acquisition of BullionFX | Alchemy assets, positioning it as a transformational move into blockchain-enabled financial infrastructure.
-
Significant Dilution Confirmed
The filing explicitly states that the proposed all-stock acquisition will result in "significant dilution" to current stockholders, underscoring the substantial impact of the deal relative to the company's current market capitalization.
Analysis · MEHA · Life Sciences
This filing serves as a critical reminder for shareholders to vote on a reverse stock split, which is necessary to maintain Nasdaq listing, and provides management's strategic rationale for the previously announced, massively dilutive $142.9 million all-stock acquisition of BullionFX | Alchemy. The acquisition, which is orders of magnitude larger than the company's current market cap, is explicitly noted as causing "significant dilution" to existing stockholders, reinforcing the negative financial implications for current investors.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEHA was trading at $0.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $0.06 to $8.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.